https://www.nature.com/articles/d41586-023-00400-x
0
0
2/15/23 at 10:11am
Organization
Nature.com
42 words
0
Comments
The approval of an antibody therapy that pauses the progression of type 1 diabetes is a first in the field, and some say a model for other drug developers.
You are the first to view
Create an account
or login to join the discussion